Raphael Dahmen
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Surgery top 10%
- Pancreatic function and diabetes
Papers in
-
- Diabetes Management and Research 8
- Diabetes Treatment and Management 6
- Surgery 6
- Pancreatic function and diabetes 6
- Co-authors
- R. H. A. Becker (4 shared papers)Tim Heise (3 shared papers)Karin Bergmann (2 shared papers)Thomas Jax (1 shared paper)Anne Lehmann (1 shared paper)Ronald Schmidt (2 shared papers)Geremia B. Bolli (1 shared paper)David R. Powell (2 shared papers)
- Journals
- Diabetes Care (3 papers)Diabetes Obesity and Metabolism (2 papers)Diabetes & Metabolism (1 paper)Journal of Diabetes Science and Technology (1 paper)Diabetes Technology & Therapeutics (1 paper)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Raphael Dahmen
11 papers receiving 731 citations
Raphael Dahmen's Hit Papers
Peers
Comparison fields: 5 of 59
- Endocrinology, Diabetes and Metabolism 680
- Surgery 447
- Genetics 214
- Cardiology and Cardiovascular Medicine 59
- Molecular Biology 103
Countries citing papers authored by Raphael Dahmen
This map shows the geographic impact of Raphael Dahmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Dahmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Dahmen more than expected).
Fields of papers citing papers by Raphael Dahmen
This network shows the impact of papers produced by Raphael Dahmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Dahmen. The network helps show where Raphael Dahmen may publish in the future.
Co-authors
The 25 scholars most cited alongside Raphael Dahmen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | New Insulin Glargine 300 Units·mL−1 Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine 100 Units·mL−1 Hit paper breakdown → | 2014 | 292 |
| 2 | 2021 | 89 | |
| 3 | 2012 | 81 | |
| 4 | 2014 | 80 | |
| 5 | 2014 | 76 | |
| 6 | 2017 | 69 | |
| 7 | 2016 | 30 | |
| 8 | 2022 | 19 | |
| 9 | 2016 | 9 | |
| 10 | Hormonal inducibility of liver-specific enzymes in cultured rat embryos. | 1986 | 7 |
| 11 | 2017 | 3 |
About Raphael Dahmen
Raphael Dahmen is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Pediatrics, Perinatology and Child Health, Genetics and Cardiology and Cardiovascular Medicine, having authored 11 papers that have together received 755 indexed citations. Recurring topics across this work include Diabetes Management and Research (8 papers), Pancreatic function and diabetes (6 papers), Diabetes Treatment and Management (6 papers), Diabetes and associated disorders (3 papers), Pharmaceutical studies and practices (2 papers), Cardiovascular Function and Risk Factors (2 papers), Cardiac electrophysiology and arrhythmias (1 paper) and Birth, Development, and Health (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (680 citations), Surgery (447 citations), Genetics (214 citations), Cardiology and Cardiovascular Medicine (59 citations) and Molecular Biology (103 citations). Raphael Dahmen has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include R. H. A. Becker, Tim Heise, Karin Bergmann, Thomas Jax, Anne Lehmann, Ronald Schmidt, Geremia B. Bolli, David R. Powell, Oliver Klein and Jeremy Pettus. Their work appears in journals such as Diabetes Care, Diabetes Obesity and Metabolism, Diabetes & Metabolism, Journal of Diabetes Science and Technology and Diabetes Technology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.